Wolfe, Andrew Lerner

Publications

Sort by

Co-Author Network

Targeting cancer's sweet spot: UGP2 as a therapeutic vulnerability. Molecular & cellular oncology. 2021 Academic Article GET IT
UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth. Proceedings of the National Academy of Sciences of the United States of America. 2021 Academic Article GET IT
Times cited: 19
NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer. Communications biology. 2021 Academic Article GET IT
Times cited: 20
NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy. Cancers. 2021 Academic Article GET IT
Times cited: 14
Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia. Science signaling. 2014 Academic Article GET IT
Times cited: 39
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer. Nature. 2014 Academic Article GET IT
Times cited: 469
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell. 2011 Academic Article GET IT
Times cited: 142
Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma. The Journal of experimental medicine. 2011 Academic Article GET IT
Times cited: 100
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nature cell biology. 2010 Academic Article GET IT
Times cited: 304